Providing a practical framework for clinicians in this rapidly changing field, Clinician’s Guide to Cellular Immunotherapy, by Dr. Utkarsh H. Acharya, is a unique, authoritative manual for healthcare professionals who manage patients receiving cellular immunotherapies. This concise, clearly written reference covers both established and emerging therapeutic modalities, offering an overview of the basic science and technology of cellular immunotherapy as well as real-world guidance on safe and effective patient management.
Contains detailed chapters ranging from types of cellular immunotherapies to practical management considerations, long-term complications, potential mechanisms of resistance, and future directions
Bridges the gap between essential principles and clinical application across cellular immunotherapy subtypes—from the biologic underpinnings of each immune effector cell to the fundamentals of patient and therapy selection to toxicity management
Includes a comprehensive chapter with case studies and self-assessment questions to reinforce concepts in the text
Offers a standardized approach to cellular immunotherapy applicable across institutions
Provides a succinct, accessible introduction to cellular immunotherapies for hematologists, oncologists, advanced practice providers, general internists, fellows, and trainees
Contains detailed chapters ranging from types of cellular immunotherapies to practical management considerations, long-term complications, potential mechanisms of resistance, and future directions
Bridges the gap between essential principles and clinical application across cellular immunotherapy subtypes—from the biologic underpinnings of each immune effector cell to the fundamentals of patient and therapy selection to toxicity management
Includes a comprehensive chapter with case studies and self-assessment questions to reinforce concepts in the text
Offers a standardized approach to cellular immunotherapy applicable across institutions
Provides a succinct, accessible introduction to cellular immunotherapies for hematologists, oncologists, advanced practice providers, general internists, fellows, and trainees
